ArticleClinical ophthalmology (Auckland, N.Z.)2011

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile.

Wolfgang Haas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.